Large-scale testing (Phase 3)Enrolling By InvitationNCT05127954
What this trial is testing
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
Who this might be right for
Migraine
AbbVie 1,200